A Report on the Effects of Phenelzine (Nardil), a Monoamine Oxidase Inhibitor, in Depressed Patients
- 1 October 1960
- journal article
- Published by Royal College of Psychiatrists in Journal of Mental Science
- Vol. 106 (445) , 1533-1538
- https://doi.org/10.1192/bjp.106.445.1533
Abstract
Phenelzine, β-phenylethylhydrazine, of structural formula, is regarded as a potent, rapidly acting, long-lasting monoamine oxidase (M.A.O.) inhibitor. The administration of such compounds protects 5-hydroxytryptamine (serotonin) which is destroyed by M.A.O. 5-hydroxytryptamine is believed to act in the brain as a chemical mediator, the function of which is to control the pulsating action of oligodendroglial cells which supply the other brain tissues with nutrient. It has been suggested that a relative 5-hydroxytryptamine deficiency is the fundamental biochemical disorder of severe depressive states and that M.A.O. inhibitors such as phenelzine tend to promote restoration to more normal concentration and activity.Keywords
This publication has 4 references indexed in Scilit:
- Phenelzine (“Nardil”) in the Treatment of Endogenous DepressionJournal of Mental Science, 1960
- New Drugs for DepressionBMJ, 1960
- TOXIC AND OTHER SIDE EFFECTS OF NARDIL PHENELZINE SULPHATE W-1544AAmerican Journal of Psychiatry, 1960
- THERAPEUTIC RE-ORIENTATION IN SOME DEPRESSIVE STATES: CLINICAL EVALUATION OF A NEW MONO-AMINE OXIDASE INHIBITOR (W-1544-A) (PHENELZINE (NARDIL)American Journal of Psychiatry, 1959